rs745685305
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_000264.5(PTCH1):c.142G>T(p.Asp48Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,611,458 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D48A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000264.5 missense
Scores
Clinical Significance
Conservation
Publications
- basal cell nevus syndrome 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- holoprosencephaly 7Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- holoprosencephalyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151958Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000246 AC: 6AN: 244088 AF XY: 0.0000449 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1459500Hom.: 0 Cov.: 34 AF XY: 0.0000262 AC XY: 19AN XY: 726148 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151958Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74236 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
PTCH1-related disorder Uncertain:1
The PTCH1 c.142G>T variant is predicted to result in the amino acid substitution p.Asp48Tyr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0083% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Gorlin syndrome Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at